Mitsunobu Kawamura - Publications

Novel splice site mutation in GATA3 in a patient with HDR syndrome.

Journal: Clinical pediatric endocrinology : case reports and clinical investigations : official journal of the Japanese Society for Pediatric Endocrinology

Published: January 24, 2017

Effect of ezetimibe add-on therapy over 52 weeks extension analysis of prospective randomized trial (RESEARCH study) in type 2 diabetes subjects.

Journal: Lipids in health and disease

Published: January 17, 2017

Efficacy and safety of sitagliptin for the treatment of diabetes mellitus complicated by chronic liver injury.

Journal: SpringerPlus

Published: February 28, 2015

Effect of Ezetimibe on LDL-C Lowering and Atherogenic Lipoprotein Profiles in Type 2 Diabetic Patients Poorly Controlled by Statins.

Journal: PloS one

Published: November 04, 2014

A Case of Rathke's Cleft Cyst Associated with Transient Central Adrenal Insufficiency and Masked Diabetes Insipidus.

Journal: Case reports in endocrinology

Published: August 23, 2014

Well-defined iron complexes as efficient catalysts for "green" atom-transfer radical polymerization of styrene, methyl methacrylate, and butyl acrylate with low catalyst loadings and catalyst recycling.

Journal: Chemistry (Weinheim an der Bergstrasse, Germany)

Published: November 23, 2013

RESEARCH (Recognized effect of Statin and ezetimibe therapy for achieving LDL-C Goal), a randomized, doctor-oriented, multicenter trial to compare the effects of higher-dose statin versus ezetimibe-plus-statin on the serum LDL-C concentration of Japanese type-2 diabetes patients design and rationale.

Journal: Lipids in health and disease

Published: July 17, 2013

Lowering LDL cholesterol, but not raising LDL receptor activity, by ezetimibe.

Journal: Journal of clinical lipidology

Published: April 03, 2013